2篇
您的检索式：作者名="Mishra Subrat"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ore petrography of low-grade siliceous manganese ores from the Bonai-Keonjhar belt, Orissa, India: The influence of mineral-fabric on their beneficiation显示文摘Low grade siliceous manganese ores from the iron ore group of the Bonai-Keonjhar belt, Orissa, India are found mostly in shear zones. The ore characteristics of siliceous manganese ore samples from three differ- ent mines, viz. the Shankar (Barbil OMC lease hold area), the Sone-Patuli (Patmunda, OMM lease hold area), and the Musaghar (Roida, OMDC lease hold area), were studied. These siliceous manganese ores are of three types, respectively: (i) spongy-granular; (ii) massive-mosaic; and (iii) hard-mylonitized. The spongy-gran- ular type contains granular, saccharoidal quartz and the major manganese mineral present is pyrolusite. The second type contains well crystallized quartz and cryptomelane, while the third has cherty, fine grained quartz (mylonite) along with romanechite. All three ores were subjected to physical beneficiation under similar conditions. Both gravity and magnetic separation techniques were employed. The mineral-fabric of the ores has been correlated to the extent of their beneficiation using these physical techniques. Of these three ores only the spongy-granular type responded well to upgrading. The feed with 22% Mn content could be upgraded to 44% with a 28% yield and a 49% recovery. The good response to beneficiation of the spongy- granular sample could be due to the large euhedral crystals of pyrolusite and the friable nature of the sac- charoidal quartz. This study reveals the influence of mineral-fabric on beneficiation of low grade ore, siliceous Mn ore in particular. | Mishra Subrat Mohapatra Birendra Kumar Dash Nilima Rao Danda Srinivas | 2011 | Mining Science and Technology2011，21，6： | 2 |
| 2 | Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome显示文摘BACKGROUND There is scant literature on hepatocellular carcinoma(HCC)in patients with Budd-Chiari syndrome(BCS).AIM To assess the magnitude,clinical characteristics,feasibility,and outcomes of treatment in BCS-HCC.METHODS A total of 904 BCS patients from New Delhi,India and 1140 from Mumbai,India were included.The prevalence and incidence of HCC were determined,and among patients with BCS-HCC,the viability and outcomes of interventional therapy were evaluated.RESULTS In the New Delhi cohort of 35 BCS-HCC patients,18 had HCC at index presentation(prevalence 1.99%),and 17 developed HCC over a follow-up of 4601 person-years,[incidence 0.36(0.22-0.57)per 100 person-years].BCS-HCC patients were older when compared to patients with BCS alone(P=0.001)and had a higher proportion of inferior vena cava block,cirrhosis,and long-segment vascular obstruction.The median alpha-fetoprotein level was higher in patients with BCS-HCC at first presentation than those who developed HCC at follow-up(13029 ng/mL vs 500 ng/mL,P=0.01).Of the 35 BCS-HCC,26(74.3%)underwent radiological interventions for BCS,and 22(62.8%)patients underwent treatment for HCC[transarterial chemoembolization in 18(81.8%),oral tyrosine kinase inhibitor in 3(13.6%),and transarterial radioembolization in 1(4.5%)].The median survival among patients who underwent interventions for HCC compared with those who did not was 3.5 years vs 3.1 mo(P=0.0001).In contrast to the New Delhi cohort,the Mumbai cohort of BCS-HCC patients were predominantly males,presented with a more advanced HCC[Barcelona Clinic Liver Cancer C and D],and 2 patients underwent liver transplantation.CONCLUSION HCC is not uncommon in patients with BCS.Radiological interventions and liver transplantation are feasible in select primary BCS-HCC patients and may improve outcomes. | Ankit Agarwal Sagnik Biswas Shekhar Swaroop Arnav Aggarwal Ayush Agarwal Gautam Jain Anshuman Elhence Arun Vaidya Amit Gupte Ravi Mohanka Ramesh Kumar Ashwani Kumar Mishra Shivanand Gamanagatti Shashi Bala Paul Subrat Kumar Acharya Akash Shukla Shalimar | 2024 | World Journal of Gastrointestinal Oncology2024，16，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员